OQS
ZVRA icon

Occudo Quantitative Strategies’s Zevra Therapeutics ZVRA Stock Holding History

Occudo Quantitative Strategies’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,138
Closed -$125K – 910
2025
Q2 		$125K Buy
+14,138
New +$115K 0.01% 562
2023
Q4 		– Sell
-22,615
Closed -$109K – 1259
2023
Q3 		$109K Buy
22,615
+6,404
+40% +$32K 0.01% 871
2023
Q2 		$82.7K Sell
16,211
-1,761
-10% -$9.49K 0.01% 942
2023
Q1 		$98.8K Buy
17,972
+4,457
+33% +$23.6K 0.01% 821
2022
Q4 		$62K Sell
13,515
-13,797
-51% -$70.1K 0.01% 875
2022
Q3 		$170K Sell
27,312
-15,036
-36% -$85.2K 0.01% 984
2022
Q2 		$189K Sell
42,348
-16,638
-28% -$75.8K 0.02% 923
2022
Q1 		$297K Buy
+58,986
New +$375K 0.02% 825

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return